Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Blood-based next-generation sequencing analysis of neuroendocrine neoplasms

12 May 2020

Abstract excerpt

// Katerina Zakka 1 , Rebecca Nagy 2 , Leylah Drusbosky 2 , Mehmet Akce 1 , Christina Wu 1 , Olatunji B. Alese 1 , Bassel F. El-Rayes 1 , Pashtoon Murtaza Kasi 3 , Kabir Mody 4 , Jason Starr 4 and Walid L. Shaib 1 1 Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA 2 Guardant Health, Redwood City, CA, USA 3 Department of Hematology and Medical Oncology,...

Topics

Join the communities discussing this publication.

Lung Cancer Research Studies
Neuroblastoma Research and Treatments
Neuroendocrine Tumor Research Advances

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 32477464
DOI: 10.18632/oncotarget.27588

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Blood-based next-generation sequencing analysis of neuroendocrine neoplasmsPMID 32477464Read ↗

Longitudinal Copy-Number Alteration Analysis in Plasma Cell-Free DNA of Neuroendocrine Neoplasms is a Novel Specific Biomarker for Diagnosis, Prognosis, and Follow-upSemantic proximity Read ↗

Evaluation of therapeutic agent selection based on comprehensive genomic profiling in gastroenteropancreatic neuroendocrine neoplasmsSemantic proximity Read ↗

Circulating Tumor DNA Profiling Identifies Actionable Mutations as Prognostic Markers in Advanced Neuroendocrine Tumors.Semantic proximity Read ↗

The Mutational, Prognostic, and Therapeutic Landscape of Neuroendocrine Neoplasms.Semantic proximity Read ↗

The emerging clinical relevance of genomic profiling in neuroendocrine tumours.Semantic proximity Read ↗

In-depth analysis of the genomic landscape of 86 metastatic neuroendocrine neoplasms reveals subtype-heterogeneity and potential therapeutic targetsSemantic proximity Read ↗

Assessment of pancreatic neuroendocrine tumor cytologic genotype diversity to guide personalized medicine using a custom gastroenteropancreatic next-generation sequencing panelSemantic proximity Read ↗

Genomic and transcriptomic landscapes of metastatic neuroendocrine neoplasms from distinct primary sites and their clinical implicationsSemantic proximity Read ↗

Clinical utility of plasma cell-free DNA in pancreatic neuroendocrine neoplasms.Semantic proximity Read ↗

Molecular Classification of Gastrointestinal and Pancreatic Neuroendocrine Neoplasms: Are We Ready for That?Semantic proximity Read ↗

Molecular pathology and genetics of gastrointestinal neuroendocrine tumours.Semantic proximity Read ↗

Tumor mutation burden in gastro-entero-pancreatic-neuroendocrine neoplasmsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.